【绿康生化:公司股票交易可能被实施退市风险警示】绿康生化公告,预计2024年期末净资产为-2300万元,归属上市公司股东的净利润为亏损4.35亿元–3.85亿元。根据《深圳证券交易所股票上市规则》规定,公司股票交易将在2024年年度报告披露后被实施退市风险警示(*ST)。此外,公司股票也可能被实施其他风险警示(ST),因公司最近连续三个会计年度扣除非经常性损益前后净利润均为负值,且最近一年审计报告显示公司持续经营能力存在不确定性。

金融界
23 Apr
绿康生化公告,预计2024年期末净资产为-2300万元,归属上市公司股东的净利润为亏损4.35亿元–3.85亿元。根据《深圳证券交易所股票上市规则》规定,公司股票交易将在2024年年度报告披露后被实施退市风险警示(*ST)。此外,公司股票也可能被实施其他风险警示(ST),因公司最近连续三个会计年度扣除非经常性损益前后净利润均为负值,且最近一年审计报告显示公司持续经营能力存在不确定性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10